Allen Krantz
Plus aucun poste en cours
Profil
Alexander Krantz is the founder of Advanced Proteome Therapeutics Corp.
(founded in 2005) and Cortria Corp.
(founded in 2005).
At Advanced Proteome Therapeutics Corp., he held the titles of COO, Secretary, Director & CSO from 2005 to 2018.
He also held the position of President at Cortria Corp.
from 2005 to 2012.
Dr. Krantz's former jobs include CEO, CFO, Treasurer, Secretary & Director at Advanced Proteome Therapeutics, Inc. from 2002 to 2018, Director at Select Therapeutics, Inc. from 1999 to 2018, Director-Patents & Licensing at the University of South Florida from 2000 to 2003, Executive Director at University of South Florida Research Foundation, Inc. from 2000 to 2003, Executive Vice President-Research at Redcell Canada, Inc. from 1994 to 1997, Assistant Vice Chancellor at the University of California, Berkeley from 2003 to 2004, and Vice President-Research at Syntex Research Canada from 1981 to 1994.
Dr. Krantz received a doctorate degree from Yale University in 1967 and a graduate degree from Yale University in 1962.
Anciens postes connus de Allen Krantz
| Sociétés | Poste | Fin |
|---|---|---|
Select Therapeutics, Inc.
 Select Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Select Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is focused on the development of cell based therapeutics production. The company was founded by Clifford A. Lingwood in January 1997 and is headquartered in Brookline, MA. | Directeur/Membre du Conseil | 29/12/2018 |
Advanced Proteome Therapeutics, Inc.
 Advanced Proteome Therapeutics, Inc. BiotechnologyHealth Technology Part of Advanced Proteome Therapeutics Corp., Advanced Proteome Therapeutics Inc. is a company that has developed a proprietary approach for streamlining the production and targeted delivery of anti-cancer drugs to cancerous tumors. The company is based in Boston, MA. The company's work allows cancer drugs to be efficiently produced and delivered to cancerous tumors in a targeted fashion that doesn't destroy the patient's normal healthy cells indiscriminately. The benefit of targeted therapies, such as Advanced Proteome's approach, is their ability to home in on cancer cells while sparing healthy cells, thereby avoiding the nasty side effects of traditional chemotherapeutics. The CEO of the company is Benjamin Alexander Krantz. | Directeur Général | 29/12/2018 |
| ADVANCED PROTEOME THERAPEUTICS CORPORATION | Fondateur | 20/12/2018 |
| University of California, Berkeley | Corporate Officer/Principal | 01/05/2004 |
| University of South Florida Research Foundation, Inc. | Corporate Officer/Principal | 01/04/2003 |
Formation de Allen Krantz
| Yale University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ADVANCED PROTEOME THERAPEUTICS CORPORATION | Health Technology |
| Entreprise privées | 6 |
|---|---|
Select Therapeutics, Inc.
Select Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Select Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is focused on the development of cell based therapeutics production. The company was founded by Clifford A. Lingwood in January 1997 and is headquartered in Brookline, MA. | Health Technology |
Cortria Corp.
 Cortria Corp. Pharmaceuticals: MajorHealth Technology Cortria Corp. operates as a clinical-stage pharmaceutical company that focuses on developing medicines to fight cardiovascular disease. Its product is used for the treatment of dyslipidemia, an atherogenic disorder characterized by abnormal lipid levels in the bloodstream. The company was founded in August 2005 and is headquartered in Needham, MA. | Health Technology |
Redcell Canada, Inc.
 Redcell Canada, Inc. Electrical ProductsProducer Manufacturing Part of Infobooth, Inc., Redcell Canada, Inc. markets and distributes quality portable power batteries. The company is based in Vancouver, Canada. Redcell Canada was acquired by Infobooth, Inc. on May 23, 2002. | Producer Manufacturing |
| Syntex Research Canada | |
Advanced Proteome Therapeutics, Inc.
Advanced Proteome Therapeutics, Inc. BiotechnologyHealth Technology Part of Advanced Proteome Therapeutics Corp., Advanced Proteome Therapeutics Inc. is a company that has developed a proprietary approach for streamlining the production and targeted delivery of anti-cancer drugs to cancerous tumors. The company is based in Boston, MA. The company's work allows cancer drugs to be efficiently produced and delivered to cancerous tumors in a targeted fashion that doesn't destroy the patient's normal healthy cells indiscriminately. The benefit of targeted therapies, such as Advanced Proteome's approach, is their ability to home in on cancer cells while sparing healthy cells, thereby avoiding the nasty side effects of traditional chemotherapeutics. The CEO of the company is Benjamin Alexander Krantz. | Health Technology |
| University of South Florida Research Foundation, Inc. |
